You are here

layoffs

Gilead cuts cardiopulmonary sales reps

Gilead cuts cardiopulmonary sales reps

BioCentury

Gilead Sciences

Flag link:

After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT

After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT

Endpoints

Flag link:

Merrimack zero for 3 as it dumps cancer drug over safety fears, axes staffers (again)

Merrimack zero for 3 as it dumps cancer drug over safety fears, axes staffers (again)

Fierce Biotech

Merrimack Pharmaceuticals

Flag link:

Recro Pharma to Lay Off 50 Following Second FDA Rejection for Non-Opioid Pain Treatment

Recro Pharma to Lay Off 50 Following Second FDA Rejection for Non-Opioid Pain Treatment

BioSpace

non-opioid pain treatments

Flag link:

Sanofi plans sales layoffs—again—in primary care, diabetes

Sanofi plans sales layoffs—again—in primary care, diabetes

Fierce Pharma

Flag link:

Obalon to lay off half its workforce in retail pivot

Obalon to lay off half its workforce in retail pivot

Mass Device

Flag link:

Janssen laying off 4 dozen employees as California plant heads toward closure

Janssen laying off 4 dozen employees as California plant heads toward closure

Fierce Pharma

drug manufacturing

Flag link:

First AbbVie chopped a PhIII, then they wrote off $4B in book value. Now 178 Stemcentrx workers are getting the ax

First AbbVie chopped a PhIII, then they wrote off $4B in book value. Now 178 Stemcentrx workers are getting the ax

Endpoints

Flag link:

Bayer to cut 200 jobs at U.S. logistics center as it alters course for pharma

Bayer to cut 200 jobs at U.S. logistics center as it alters course for pharma

Fierce Pharma

Flag link:

Vical stops antifungal trial, lays off staff to eke out cash

Vical stops antifungal trial, lays off staff to eke out cash

Fierce Biotech

Flag link:

Layoffs Hit California Biopharma Companies

Layoffs Hit California Biopharma Companies

BioSpace

Flag link:

Ironwood to cut 35 more jobs as company split nears

Ironwood to cut 35 more jobs as company split nears

BioPharma Dive

Ironwood Pharmaceuticals

Flag link:

New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts

New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts

Fierce Biotech

Seres Therapeutics

Flag link:

Pharma is shuffling around jobs, but a skills gap threatens the process

Pharma is shuffling around jobs, but a skills gap threatens the process

BioPharma Dive

pharma industry

Flag link:

Where are pharma's biggest layoffs happening?

Where are pharma's biggest layoffs happening?

BioPharma Dive

pharma industry

Flag link:

‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts

‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts

Fierce Pharma

drug manufacturing

Flag link:

Histogenics to lay off 65% of workforce, including CMO & CBO, in restructuring

Histogenics to lay off 65% of workforce, including CMO & CBO, in restructuring

Mass Device

Flag link:

Microbiome test maker uBiome cuts 55 jobs to sharpen focus on drugs, partnerships —

Microbiome test maker uBiome cuts 55 jobs to sharpen focus on drugs, partnerships —

Endpoints

Flag link:

Five Prime Therapeutics Cuts 20% of Staff as Part of Restructuring

Five Prime Therapeutics Cuts 20% of Staff as Part of Restructuring

BioSpace

Five Prime Therapeutics

Flag link:

Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs

Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs

Endpoints

Flag link:

Pages